BWA
45
3
LRCX
61
2
PRGO
36
3
VFC
58
2
DNB
58
2
ADBE
55
4
AES
49
-2
DG
14
2
ORLY
48
-4
ECL
54
-3
MPC
33
2
ED
42
2
MAT
45
2
PVH
59
-3
ROP
50
2
TROW
50
2
CVS
32
3
ESS
51
3
USB
53
3
PLD
45
5
BWA
45
3
LRCX
61
2
PRGO
36
3
VFC
58
2
DNB
58
2
ADBE
55
4
AES
49
-2
DG
14
2
ORLY
48
-4
ECL
54
-3
MPC
33
2
ED
42
2
MAT
45
2
PVH
59
-3
ROP
50
2
TROW
50
2
CVS
32
3
ESS
51
3
USB
53
3
PLD
45
5
Financhill
Back

Dyne Therapeutics 10K Form

Sell
26

DYN
Dyne Therapeutics

Last Price:
$24.47
Seasonality Move:
12.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DYN News And Ratings

See the #1 stock for the next 7 days that we like better than DYN

DYN Financial Statistics

Sales & Book Value

Annual Sales: $4.8B
Cash Flow: $-74.9M
Price / Cash Flow: 0
Annual Sales: $6.93
Price / Book: 3.53

Profitability

EPS (TTM): -3.56000
Net Income (TTM): $-294.5M
Gross Margin: $1.9B
Return on Equity: 0%
Return on Assets: 0%

Dyne Therapeutics Earnings Forecast

Key Dyne Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 13 years for DYN is 39.45%.
  • The Selling, General & Administrative Expenses for DYN have been equal to 3.90% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Dyne Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DYN
CUSIP: 26818M
Website: dyne-tx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DYN Technical Analysis vs Fundamental Analysis

Sell
26
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy or a Sell?

  • Dyne Therapeutics stock is rated a Sell
    The current Dyne Therapeutics [DYN] share price is $24.47. The Score for DYN is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.